Sana Biotechnology (SANA) Profit After Tax (2020 - 2026)

Sana Biotechnology has reported Profit After Tax for 7 years, with the latest figure at -$47.2 million in Q1 2026.

• Quarterly Profit After Tax rose 4.38% year-over-year to -$47.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$242.0 million (down 15.97% YoY) and the FY2025 annual result came in at -$244.2 million, up 8.47% from the prior year.
• Profit After Tax advanced to -$47.2 million in Q1 2026 per SANA's latest filing, from -$58.8 million in the prior quarter.
• Over five years, Profit After Tax peaked at $1.6 million in Q3 2023 and troughed at -$114.0 million in Q2 2023.
• A 5-year average of -$65.5 million and a median of -$59.9 million in 2024 frame the typical range for Profit After Tax.
• The sharpest annual moves came in 2023 and 2024: Profit After Tax jumped 101.93% in 2023, then plunged 3738.37% in 2024.
• Over 5 years, Profit After Tax stood at -$83.4 million in 2022, then declined by 5.65% to -$88.1 million in 2023, then surged by 44.31% to -$49.1 million in 2024, then retreated by 19.88% to -$58.8 million in 2025, then grew by 19.69% to -$47.2 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$47.2 million, -$58.8 million, and -$42.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.